This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Redsense Medical receives Notice of Allowance from U.S. Patent and Trademark Office for patent application f or the catheter sensor solution.
Redsense Medical announces today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application 16/333,571 (https://portal.uspto.gov/pair/PublicPair), “A device for monitoring… [read more]
Redsense Medical AB (publ) (”Redsense” eller ”Bolaget”) höll under fredagen den 18 december 2020 extra bolagsstämma varvid följande huvudsakliga beslut fattades. För detaljerad information om… [read more]